Patient reported nonadherence in psoriasis patients receiving adalimumab or ustekinumab

被引：0
|
作者：
Goren, Amir [1 ]
Carter, Chureen [2 ]
Lee, Seina [2 ]
机构：
[1] Kantar Hlth, New York, NY USA
[2] Janssen Sci Affairs LLC, Horsham, PA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
1358
引用
收藏
页码：AB241 / AB241
页数：1
相关论文
共 50 条
  • [11] Topical treatment habits in psoriasis patients receiving adalimumab
    Kolios, Antonios G. A.
    Navarini, Alexander A.
    Rusca, Franzisca
    Reisenbauer, Karin
    French, Lars
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB205 - AB205
  • [12] Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or Ustekinumab
    Carter, Chureen
    Wilson, Kathleen L.
    Smith, David
    Lee, Seina
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (05) : 191 - 198
  • [13] Patient choice of dosing frequency among moderate-to-severe plaque psoriasis patients with adalimumab, etanercept, and/or ustekinumab experience
    Carter, Chureen
    Farahi, Kamyar
    Johnson, Michael P.
    Olson, William
    Zhang, Mingliang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB262 - AB262
  • [14] Effects of adalimumab monotherapy versus adalimumab plus betamethasone/calcipotriol combination therapy on patient-reported outcomes in psoriasis patients
    Thaci, Diamant
    Xie, Jipan
    Mulani, Parvez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB127 - AB127
  • [15] Effects of adalimumab monotherapy versus adalimumab plus betamethasone/calcipotriol on patient-reported outcomes in psoriasis patients with psoriatic arthritis
    Thaci, Diamant
    Xie, Jipan
    Mulani, Parvez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB135 - AB135
  • [16] Characteristics of patients newly initiating ustekinumab, adalimumab, secukinumab, apremilast or methotrexate for plaque psoriasis
    Lee, Seina
    Carroll, Charlotte
    Pericone, Christopher
    Tunceli, Ozgur
    Fakharzadeh, Steve
    Feldman, Steve
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB66 - AB66
  • [17] Characterizing patients with psoriasis on injectable biologics adalimumab, etanercept, and ustekinumab: A chart review study
    Zhang, Mingliang
    Goren, Amir
    Lee, Seina
    DiBonaventura, Marco D.
    Olson, William H.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (04) : 339 - 345
  • [18] The benefits of adalimumab on clinical and patient-reported outcomes among moderate to severe psoriasis patients with comorbidities
    Kimball, Alexa
    Chen, Lei
    Mulani, Parvez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB95 - AB95
  • [19] Patient-reported outcomes with etanercept therapy in patients with plaque psoriasis who lost response to adalimumab
    Papp, Kim A.
    Tyring, Stephen
    Stolshek, Bradley S.
    Rice, Kara Creamer
    Collier, David H.
    Kricorian, Greg
    Iles, Jan
    Kaliyaperumal, Arunan
    Bagel, Jerry
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB191 - AB191
  • [20] Adalimumab/infliximabParadoxical psoriasis, successfully treated with ustekinumab: case report
    Reactions Weekly, 2017, 1639 (1) : 19 - 19
12345